Reuters logo
BRIEF-Triphase Accelerator announces new collaboration with Celgene Corp for TRPH-222
December 21, 2016 / 2:43 PM / 10 months ago

BRIEF-Triphase Accelerator announces new collaboration with Celgene Corp for TRPH-222

Dec 21 (Reuters) - Triphase Accelerator:

* Triphase Accelerator- pursuant to agreement, triphase accelerator received an upfront payment from celgene

* Triphase Accelerator - Celgene has an option to acquire all Triphase Accelerator’s assets relating to trph-222

* Triphase Accelerator announces new collaboration with Celgene Corporation for trph-222, an anti-cd22 antibody drug conjugate

* Triphase Accelerator- if Celgene exercises its option to acquire TRPH-222, Celgene will become responsible for development and commercialization Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below